AFP with AFP-L3%

Test ID: 


CPT code:



•AFP With AFP-L3%
•Alpha-Fetoprotein (AFP) With AFP-L3%

Clinical Use:

The AFP-L3% assay is intended for use in the assessment of risk for the development of hepatocellular carcinoma (HCC) in patients with chronic liver diseases.1

Additional Test information:

Serum AFP levels are markedly elevated in the neonate because AFP is synthesized in large quantities during embryonic development by the fetal yolk sac and by the fetal liver.2 Serum AFP concentrations decrease gradually after birth until they reach adult levels by 12 to 18 months of age.2 Due to fetal production, AFP becomes elevated in maternal serum during pregnancy.2 Pathologically, increased AFP levels have been associated with both acute and chronic liver disease as well as hepatocellular carcinoma (HCC).2,3 AFP can also be elevated in a number of other malignancies including gastric, lung, pancreatic, biliary tract, and testicular carcinomas.2 Patients with chronic liver disease are at a greatly increased risk for developing HCC.2,3 Early detection of HCC is important, especially in high-risk populations.3 Unfortunately, increased AFP is often observed in patients with chronic liver disease that has not progressed to HCC.2,3 This serves to limit the utility of AFP measurements as an early indicator of progression to HCC in these patients.2,3

Specimen Type:


Requested Volume: 

0.5 mL

Minimum Volume: 

0.2 mL

Container Type: 

Red-top tube or gel-barrier tube


If a red-top tube is used, transfer separated serum to a plastic transport tube

Storage Instructions:


Rejection Criteria

Nonserum specimen received

Return Back to Test Directory

MCI Diagnostic

Providing top patient care with fast results. 

7018 South Utica Avenue

Tulsa, Oklahoma 74136

Hours of Operation

Mon – Sat: 7AM-11PM

Sun: 7AM-3PM

Government Contract

Mon – Sat: 7AM-11PM

Sun: 7AM-3PM


Mon – Sat: 7AM-11PM

Sun: 7AM-3PM

Thank you for uploading your files. Your upload has been submitted successfully.